Metabolic Syndrome and Heart Transplantation: An Underestimated Risk Factor?

Metabolic Syndrome and Heart Transplantation: An Underestimated Risk Factor?

Metabolic Syndrome (MetS), a multifactorial condition that increases the risk of cardio-vascular events, is frequent in Heart-transplant (HTx) candidates and worsens with immunosuppressive therapy. The aim of the study was to analyze the impact of MetS on long-term outcome of HTx patients. Since 200...

Full description

Bibliographic Details
Main Authors: Sandro Sponga, Igor Vendramin, Veronica Ferrara, Michela Marinoni, Giulia Valdi, Concetta Di Nora, Chiara Nalli, Giovanni Benedetti, Daniela Piani, Andrea Lechiancole, Maria Parpinel, Uberto Bortolotti, Ugolino Livi
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-03-01
Series:Transplant International
Subjects:
heart transplantation
metabolic syndrome
cardiac allograft vasculopathy
long-term mortality
long-term outcome
Online Access:https://www.frontierspartnerships.org/articles/10.3389/ti.2024.11075/full

Internet

https://www.frontierspartnerships.org/articles/10.3389/ti.2024.11075/full

Similar Items